Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
6621
-
6622
The optimal treatment of invasive ductal and lobular carcinoma occurring at the same time needs to be established
Published 2025-01-01“…The case highlights the need for further research into the optimal treatment strategies for synchronous breast cancers, a potential knowledge gap in current oncology practice. A literature review revealed limited reports addressing similar cases, underscoring the lack of consensus guidelines. …”
Get full text
Article -
6623
-
6624
Stemness-related gene signatures as a predictive tool for breast cancer radiosensitivity
Published 2025-01-01Get full text
Article -
6625
Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway
Published 2024-02-01Get full text
Article -
6626
-
6627
-
6628
-
6629
MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway
Published 2019-01-01Get full text
Article -
6630
Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients
Published 2025-02-01Get full text
Article -
6631
-
6632
-
6633
An innovative approach to hospital-wide interprofessional capacity building: Côte d’Ivoire National Cancer Center project
Published 2025-01-01“…As a part of The National Radiotherapy and Medical Oncology Center Project in Côte d’Ivoire, the National Cancer Center Korea has initiated a training project for hospital personnel in Côte d’Ivoire. …”
Get full text
Article -
6634
The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
Published 2025-01-01“…Yujing Xin,1 Ning Liu,2 Gang Peng,3 Xiaoyu Huang,3 Xiaojing Cao,3 Xiang Zhou3 1Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People’s Republic of China; 2School of Software, Shandong University, Jinan, Shandong, 250101, People’s Republic of China; 3National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaCorrespondence: Xiang Zhou, Email zhou.xiang@yeah.netPurpose: To investigate the prognostic value of inflammatory indexes based on peripheral blood cells in unresectable hepatocellular carcinoma (HCC) patients treated with Lenvatinib combined with PD-1 inhibitors.Methods: This study retrospectively collected baseline inflammatory indexes from HCC patients received Lenvatinib and PD-1 inhibitor-based combination therapy at the Cancer Hospital of the Chinese Academy of Medical Sciences between October 2018 and October 2021. …”
Get full text
Article -
6635
-
6636
-
6637
-
6638
-
6639
-
6640